ArticleLeukemia research2013

A phase I study using bortezomib with weekly idarubicin for treatment of elderly patients with acute myeloid leukemia.

Dianna S Howard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.